vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(1.17) per share. This is a 51.25 percent increase over losses of $(2.40) per share from the same period last year. The company reported $1.00 million in sales this quarter.
VTv Therapeutics Q1 EPS $(1.17) Up From $(2.40) YoY, Sales $1.00M
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.